The FDA-approved criteria for semaglutide (Wegovy) include adults with a BMI of 30 or greater (obesity), or adults with a BMI of 27 or greater (overweight) who have at least one weight-related comorbidity such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea
In 2024, Ozempic and Wegovy had price tags of right at or over $1,000 per month
However, once you have access, it is easy to compare and pricing for each treatment option is clear
Clinical trials have shown significant weight reduction in many patients using the medication
Participants who took the highest dose (2.4 mg weekly) lost an average of 10.6% of their total body weight after 20 weeks and about 15% of their body weight at 68 weeks
But as far as service goes they are on top of things